Détail du document
Identifiant
doi:10.1186/s13578-024-01225-5...
Auteur
Chen, Tao Zheng, Liying Luo, Peiyue Zou, Jun Li, Wei Chen, Qi Zou, Junrong Qian, BiaoLangue
enEditeur
BioMed Central
Catégorie
Life Sciences
Année
2024
Date de référencement
10/04/2024
Mots clés
autophagy m6a modification cancer duality cancer therapy m6a role modification cancer autophagyRésumé
Autophagy is a cellular self-degradation process that plays a crucial role in maintaining metabolic functions in cells and organisms.
Dysfunctional autophagy has been linked to various diseases, including cancer.
In cancer, dysregulated autophagy is closely associated with the development of cancer and drug resistance, and it can have both oncogenic and oncostatic effects.
Research evidence supports the connection between m6A modification and human diseases, particularly cancer.
Abnormalities in m6A modification are involved in the initiation and progression of cancer by regulating the expression of oncogenes and oncostatic genes.
There is an interaction between m6A modification and autophagy, both of which play significant roles in cancer.
However, the molecular mechanisms underlying this relationship are still unclear.
m6A modification can either directly inhibit autophagy or promote its initiation, but the complex relationship between m6A modification, autophagy, and cancer remains poorly understood.
Therefore, this paper aims to review the dual role of m6A and autophagy in cancer, explore the impact of m6A modification on autophagy regulation, and discuss the crucial role of the m6A modification-autophagy axis in cancer progression and treatment resistance.
Chen, Tao,Zheng, Liying,Luo, Peiyue,Zou, Jun,Li, Wei,Chen, Qi,Zou, Junrong,Qian, Biao, 2024, Crosstalk between m6A modification and autophagy in cancer, BioMed Central
Clinical Relevance of Plaque Distribution for Basilar Artery Stenosis
study endovascular imaging wall basilar complications plaque postoperative artery plaques stenosis
